Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products, over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions comprising eye allergies, conjunctivitis, and dry eye. The Ophthalmic Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of eye conditions, such as glaucoma, ocular hypertension, and retinal diseases; and contact lenses for therapeutic use.[ Read More ]
The intrinsic value of one BLCO stock under the base case scenario is HIDDEN Compared to the current market price of 19.7 USD, Bausch + Lomb Corporation is HIDDEN
Current Assets | 2.74 B |
Cash & Short-Term Investments | 331 M |
Receivables | 839 M |
Other Current Assets | 1.57 B |
Non-Current Assets | 10.7 B |
Long-Term Investments | 0 |
PP&E | 1.39 B |
Other Non-Current Assets | 9.31 B |
Current Liabilities | 1.58 B |
Accounts Payable | 522 M |
Short-Term Debt | 30 M |
Other Current Liabilities | 1.03 B |
Non-Current Liabilities | 4.94 B |
Long-Term Debt | 4.62 B |
Other Non-Current Liabilities | 324 M |
Revenue | 4.15 B |
Cost Of Revenue | 1.64 B |
Gross Profit | 2.5 B |
Operating Expenses | 2.37 B |
Operating Income | 130 M |
Other Expenses | 378 M |
Net Income | -248 M |
Net Income | -248 M |
Depreciation & Amortization | 382 M |
Capital Expenditures | -181 M |
Stock-Based Compensation | 74 M |
Change in Working Capital | -287 M |
Others | -75 M |
Free Cash Flow | -198 M |
Date | Value | Insider | Amount | Avg Price |
---|---|---|---|---|
3 months ago
Aug 05, 2024
|
Bought 505 K USD
|
SAUNDERS BRENT L
CEO and Chairman of the Board |
+ 32250
|
15.661 USD |
2 years ago
Jun 01, 2022
|
Sell 77.6 M USD
|
Bausch Health Companies Inc.
director: |
- 4550357
|
17.055 USD |
2 years ago
May 10, 2022
|
Sell 597 M USD
|
Bausch Health Companies Inc.
director: |
- 35000000
|
17.055 USD |